Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4DL4

Human DNA polymerase eta inserting dCMPNPP opposite the 3'G of cisplatin crosslinked Gs (Pt-GG1).

4DL4 の概要
エントリーDOI10.2210/pdb4dl4/pdb
関連するPDBエントリー3MR2 3MR3 3MR5 3MR6 3SI8
分子名称DNA polymerase eta, DNA (5'-D(P*GP*GP*CP*TP*CP*AP*CP*AP*CP*T)-3'), DNA (5'-D(*TP*AP*GP*TP*GP*TP*GP*AP*G)-3'), ... (8 entities in total)
機能のキーワードcisplatin, chemoresistence, translesion synthesis, human dna polymerse eta, kinetics, molecular splint, inhibition, dna distorsion, second tls polymerase, nucleotidyl transfer reaction, pcna, transferase-dna-inhibitor complex, transferase/dna/inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Nucleus: Q9Y253
タンパク質・核酸の鎖数3
化学式量合計55340.47
構造登録者
Zhao, Y.,Biertumpfel, C.,Gregory, M.,Hua, Y.-J.,Hanaoka, F.,Yang, W. (登録日: 2012-02-05, 公開日: 2012-05-09, 最終更新日: 2023-09-13)
主引用文献Zhao, Y.,Biertumpfel, C.,Gregory, M.T.,Hua, Y.J.,Hanaoka, F.,Yang, W.
Structural Basis for Chemoresistance to Cisplatin Mediated by DNA Polymerase eta
Proc.Natl.Acad.Sci.USA, 109:7269-7274, 2012
Cited by
PubMed Abstract: Cisplatin (cis-diamminedichloroplatinum) and related compounds cause DNA damage and are widely used as anticancer agents. Chemoresistance to cisplatin treatment is due in part to translesion synthesis by human DNA polymerase η (hPol η). Here, we report crystal structures of hPol η complexed with intrastrand cisplatin-1,2-cross-linked DNA, representing four consecutive steps in translesion synthesis. In contrast to the generally enlarged and nondiscriminating active site of Y-family polymerases like Dpo4, Pol η is specialized for efficient bypass of UV-cross-linked pyrimidine dimers. Human Pol η differs from the yeast homolog in its binding of DNA template. To incorporate deoxycytidine opposite cisplatin-cross-linked guanines, hPol η undergoes a specific backbone rearrangement to accommodate the larger base dimer and minimizes the DNA distortion around the lesion. Our structural analyses show why Pol η is inefficient at extending primers after cisplatin lesions, which necessitates a second translesion DNA polymerase to complete bypass in vivo. A hydrophobic pocket near the primer-binding site in human Pol η is identified as a potential drug target for inhibiting translesion synthesis and, thereby, reducing chemoresistance.
PubMed: 22529383
DOI: 10.1073/pnas.1202681109
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 4dl4
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon